VERTEX PHARMACEUTICALS INC / MA — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| LEIDEN JEFFREY M | Executive Chairman | Tax Withholding | 8,236 | $232.51 | $1,914,952 | 102,090 | Feb 17, 2022 |
| Kewalramani Reshma | CEO & President | Tax Withholding | 8,584 | $232.51 | $1,995,866 | 130,088 | Feb 17, 2022 |
| Bozic Carmen | EVP and CMO | Tax Withholding | 3,439 | $232.51 | $799,602 | 51,065 | Feb 17, 2022 |
| Arbuckle Stuart A | EVP, COO | Tax Withholding | 4,126 | $232.51 | $959,336 | 72,312 | Feb 17, 2022 |
| ALTSHULER DAVID | EVP, Global Research and CSO | Sale | 986 | $229.22 | $226,011 | 53,013 | Feb 17, 2022 |
| ALTSHULER DAVID | EVP, Global Research and CSO | Sale | 2,444 | $232.02 | $567,057 | 57,438 | Feb 14, 2022 |
| WAGNER CHARLES F JR | EVP & Chief Financial Officer | Tax Withholding | 2,434 | $237.74 | $578,659 | 55,001 | Feb 10, 2022 |
| Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sale | 42 | $236.85 | $9,948 | 57,737 | Feb 10, 2022 |
| Sanna Bastiano | EVP, Cell & Genetic Therapies | Tax Withholding | 979 | $237.74 | $232,747 | 53,973 | Feb 10, 2022 |
| Sachdev Amit | EVP, Chief Patient Officer | Tax Withholding | 2,491 | $237.74 | $592,210 | 59,075 | Feb 10, 2022 |
| Liu Joy | SVP, General Counsel | Tax Withholding | 474 | $237.74 | $112,689 | 16,720 | Feb 10, 2022 |
| Kewalramani Reshma | CEO & President | Tax Withholding | 3,031 | $237.74 | $720,590 | 138,672 | Feb 10, 2022 |
| Bozic Carmen | EVP and CMO | Tax Withholding | 2,437 | $237.74 | $579,372 | 54,504 | Feb 10, 2022 |
| Arbuckle Stuart A | EVP, COO | Tax Withholding | 3,040 | $237.74 | $722,730 | 76,438 | Feb 10, 2022 |
| ALTSHULER DAVID | EVP, Global Research and CSO | Sale | 98 | $237.23 | $23,249 | 59,882 | Feb 10, 2022 |
| WAGNER CHARLES F JR | EVP & Chief Financial Officer | Award / Grant | 11,628 | — | — | 50,117 | Feb 2, 2022 |
| ALTSHULER DAVID | EVP, Global Research and CSO | Sale | 754 | $249.97 | $188,477 | 68,976 | Feb 2, 2022 |
| Bozic Carmen | EVP and CMO | Award / Grant | 10,262 | — | — | 56,941 | Feb 1, 2022 |
| Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Award / Grant | 10,262 | — | — | 59,257 | Feb 1, 2022 |
| Sanna Bastiano | EVP, Cell & Genetic Therapies | Award / Grant | 12,314 | — | — | 56,518 | Feb 1, 2022 |
| Sachdev Amit | EVP, Chief Patient Officer | Award / Grant | 9,800 | — | — | 41,728 | Feb 1, 2022 |
| Liu Joy | SVP, General Counsel | Award / Grant | 3,207 | — | — | 17,194 | Feb 1, 2022 |
| LEIDEN JEFFREY M | Executive Chairman | Award / Grant | 20,928 | — | — | 99,160 | Feb 1, 2022 |
| Kewalramani Reshma | CEO & President | Award / Grant | 29,032 | — | — | 112,586 | Feb 1, 2022 |
| Arbuckle Stuart A | EVP, COO | Award / Grant | 14,623 | — | — | 79,478 | Feb 1, 2022 |
| Ambrose Kristen | SVP & Chief Accounting Officer | Award / Grant | 2,566 | — | — | 3,960 | Feb 1, 2022 |
| MCGLYNN MARGARET G | — | Sale | 1,901 | $240.53 | $457,248 | 4,198 | Jan 28, 2022 |
| Sachdev Amit | EVP, Chief Patient Officer | Sale | 30 | $187.48 | $5,624 | 31,928 | Nov 15, 2021 |
| Arbuckle Stuart A | EVP, COO | Sale | 1 | $187.80 | $188 | 41,103 | Nov 15, 2021 |
| ALTSHULER DAVID | EVP, Global Research and CSO | Sale | 14 | $186.80 | $2,615 | 33,609 | Nov 15, 2021 |
| Sanna Bastiano | EVP, Cell & Genetic Therapies | Tax Withholding | 766 | $185.07 | $141,764 | 32,576 | Nov 1, 2021 |
| Kewalramani Reshma | CEO & President | Purchase | 4,243 | $196.34 | $833,071 | 73,754 | Aug 19, 2021 |
| SACHS BRUCE I | — | Purchase | 15,000 | $197.91 | $2,968,650 | 41,210 | Aug 2, 2021 |
| Sanna Bastiano | EVP, Cell & Genetic Therapies | Tax Withholding | 766 | $200.39 | $153,499 | 33,342 | Jul 30, 2021 |
| Bhatia Sangeeta N. | — | Sale | 121 | $211.00 | $25,531 | 5,191 | Jun 2, 2021 |
| MCGLYNN MARGARET G | — | Disposition | 699 | — | — | 1,099 | Jun 1, 2021 |
| Bozic Carmen | EVP and CMO | Tax Withholding | 311 | $210.04 | $65,322 | 32,953 | May 28, 2021 |
| Sanna Bastiano | EVP, Cell & Genetic Therapies | Sale | 47 | $216.88 | $10,193 | 34,108 | May 17, 2021 |
| Sachdev Amit | EVP, Chief Patient Officer | Sale | 5 | $217.27 | $1,086 | 40,133 | May 17, 2021 |
| Liu Joy | SVP, General Counsel | Sale | 47 | $216.88 | $10,193 | 8,253 | May 17, 2021 |
| Arbuckle Stuart A | EVP, Chief Comm & Ops Officer | Sale | 16 | $217.15 | $3,474 | 41,103 | May 17, 2021 |
| ALTSHULER DAVID | EVP, Global Research and CSO | Sale | 56 | $216.31 | $12,113 | 33,604 | May 17, 2021 |
| MCKENZIE DIANA | — | Award / Grant | 1,842 | — | — | 3,277 | May 1, 2021 |
| MCGLYNN MARGARET G | — | Award / Grant | 921 | — | — | 1,798 | May 1, 2021 |
| CARNEY LLOYD | — | Award / Grant | 1,842 | — | — | 5,401 | May 1, 2021 |
| Bhatia Sangeeta N. | — | Award / Grant | 1,842 | — | — | 5,750 | May 1, 2021 |
| WAGNER CHARLES F JR | EVP & Chief Financial Officer | Tax Withholding | 547 | $217.21 | $118,814 | 34,679 | Apr 30, 2021 |
| Sanna Bastiano | EVP, Cell & Genetic Therapies | Sale | 501 | $218.06 | $109,248 | 34,567 | Apr 30, 2021 |
| Sachdev Amit | EVP, Chief Patient Officer | Sale | 1,338 | $216.67 | $289,904 | 40,333 | Apr 27, 2021 |
| Sanna Bastiano | EVP, Cell & Genetic Therapies | Sale | 389 | $214.99 | $83,631 | 35,834 | Apr 5, 2021 |